Company Filing History:
Years Active: 2010
Title: Altila Kolonics: Innovator in Pharmaceutical Composition
Introduction
Altila Kolonics is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of gastrointestinal motility disorders. His innovative approach has led to the development of a unique pharmaceutical composition that addresses various gastrointestinal issues.
Latest Patents
Altila Kolonics holds 1 patent for his invention titled "Pharmaceutical composition having prokinetic effect." This patent focuses on a method of treating gastrointestinal motility disorders in subjects in need. The method involves administering a therapeutically effective amount of O-(3-piperidino-2-hydroxypropyl) nicotinic amidoxime or a pharmaceutically suitable acid addition salt thereof. The gastrointestinal motility disorders targeted by this invention include reflux esophagitis, type II biliary and pancreatic sphincter of Oddi dysfunction, type III biliary and pancreatic sphincter of Oddi dysfunction, postcholecystectomy syndrome, non-ulcerative colitis, and fecal incontinences.
Career Highlights
Altila Kolonics is associated with N-gene Research Laboratories, Inc., where he continues to work on innovative solutions in the pharmaceutical sector. His dedication to research and development has positioned him as a key figure in his field.
Collaborations
Throughout his career, Altila has collaborated with esteemed colleagues such as Zoltan Szilvassy and Kálmán Tory. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.
Conclusion
Altila Kolonics is a prominent inventor whose work in pharmaceutical compositions has the potential to significantly impact the treatment of gastrointestinal disorders. His innovative spirit and dedication to research continue to drive advancements in the field.